REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Clinical trials for REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear
Sign up with your email to follow new studies for REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on returning leukemia in new trial
Disease control Recruiting nowThis early-stage trial tests a new treatment for children and adults (ages 0-80) whose leukemia has come back or not responded after a donor stem cell transplant. The treatment involves taking donor immune cells, adding a special receptor so they can recognize and attack leukemia…
Matched conditions: REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New drug Q702 aims to boost immune system against Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called Q702 in people with certain blood cancers or histiocytic disorders that have not responded to standard treatments. The drug works by helping the immune system attack cancer cells and supporting normal blood cell production. The study…
Matched conditions: REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC